Title

Cureus | Diffuse Alveolar Hemorrhage With Avelumab Maintenance Therapy

Department

Internal Medicine

Document Type

Article

Publication Title

Cureus

Abstract

Immune checkpoint blockade is a rapidly expanding therapeutic modality in oncology. However, its adverse effects extend beyond the cytotoxicity of conventional chemotherapy. Pneumotoxicity associated with immune checkpoint therapy presents a diagnostic conundrum that has been further complicated by the COVID-19 pandemic. We report a case of a patient with metastatic urothelial carcinoma who developed diffuse alveolar hemorrhage (DAH) following treatment with avelumab.

DOI

10.7759/cureus.15805

Publication Date

6-21-2021

Share

COinS